Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ha-Soon Choi is active.

Publication


Featured researches published by Ha-Soon Choi.


Angewandte Chemie | 1999

Total Synthesis of the CP Molecules CP-263,114 and CP-225,917— Part 1: Synthesis of Key Intermediates and Intelligence Gathering

K. C. Nicolaou; Phil S. Baran; Yong-Li Zhong; Ha-Soon Choi; Won Hyung Yoon; Yun He; Kin Chiu Fong

A synthetic labyrinth endowed with countless obstacles, yet filled with numerous hidden treasures, had to be overcome to reach the CP molecules CP-263,114 (1) and CP-225,917 (2). Their complex molecular frameworks coupled with the array of sensitive functionalities present amount to a formidable synthetic challenge. Moreover, these compounds possess interesting biological properties. Although the first synthetic strategies ended before the goals were achieved, in spite of careful preparation and numerous model studies, enough information was gathered en route to enable a revised approach to be formulated, which finally culminated in success.


Bioorganic & Medicinal Chemistry Letters | 2005

Crystal structures of human HSP90α-complexed with dihydroxyphenylpyrazoles

Andreas Kreusch; Shulin Han; Achim Brinker; Vicki Zhou; Ha-Soon Choi; Yun He; Scott A. Lesley; Jeremy S. Caldwell; Xiang-ju Gu

Abstract A series of dihydroxyphenylpyrazole compounds were identified as a unique class of reversible Hsp90 inhibitors. The crystal structures for two of the identified compounds complexed with the N-terminal ATP binding domain of human Hsp90α were determined. The dihydroxyphenyl ring of the compounds fits deeply into the adenine binding pocket with the C2 hydroxyl group forming a direct hydrogen bond with the side chain of Asp93. The pyrazole ring forms hydrogen bonds to the backbone carbonyl of Gly97, the hydroxyl group of Thr184 and to a water molecule, which is present in all of the published HSP90 structures. One of the identified compounds (G3130) demonstrated cellular activities (in Her-2 degradation and activation of Hsp70 promoter) consistent with the inhibition of cellular Hsp90 functions.


Tetrahedron Letters | 1996

Catalytic asymmetric allylation of aldehydes with BINOL-Ti(IV) complex accelerated by i-PrSSiMe3

Chan-Mo Yu; Ha-Soon Choi; Won-Hyuk Jung; Sung-Soo Lee

Abstract Practical and efficient catalytic asymmetric allylation reaction of achiral aldehydes with allyltri-n-butylstannane in the presence of chiral Lewis acid catalyst has been achieved by the use of accelerator, i-PrSSiMe3. This system exhibited not only dramatically accelerating reactivity but also significantly increasing catalytic ability.


Angewandte Chemie | 1999

A Novel Route to the Fused Maleic Anhydride Moiety of CP Molecules

K. C. Nicolaou; Phil S. Baran; Rolf Jautelat; Yun He; Kin Chiu Fong; Ha-Soon Choi; Won Hyung Yoon; Yong-Li Zhong

A seven-step cascade reaction-in which selective mesylation, epoxide formation, epoxide lysis, cyclization, reiterative oxidation, and nitrogen-oxygen exchange occur sequentially-facilitates the construction of the maleic anhydride moiety of CP molecules 1 and 2 (>93% yield per step). Unstable intermediates of this reaction sequence were detected, providing evidence for the proposed mechanism and resulting in the discovery of a new chemical entity.


ACS Medicinal Chemistry Letters | 2015

(R)-2-Phenylpyrrolidine Substituted Imidazopyridazines: A New Class of Potent and Selective Pan-TRK Inhibitors.

Ha-Soon Choi; Paul Vincent Rucker; Zhicheng Wang; Yi Fan; Pamela A. Albaugh; Greg Chopiuk; Francois Gessier; Fangxian Sun; Francisco Adrian; Guoxun Liu; Tami Hood; Nanxin Li; Yong Jia; Jianwei Che; Susan McCormack; Allen Li; Jie Li; Auzon Steffy; AnneMarie Culazzo; Celine Tompkins; Van Phung; Andreas Kreusch; Min Lu; Bin Hu; Apurva Chaudhary; Mahavir Prashad; Tove Tuntland; Bo Liu; Jennifer L. Harris; H. Martin Seidel

Deregulated kinase activities of tropomyosin receptor kinase (TRK) family members have been shown to be associated with tumorigenesis and poor prognosis in a variety of cancer types. In particular, several chromosomal rearrangements involving TRKA have been reported in colorectal, papillary thyroid, glioblastoma, melanoma, and lung tissue that are believed to be the key oncogenic driver in these tumors. By screening the Novartis compound collection, a novel imidazopyridazine TRK inhibitor was identified that served as a launching point for drug optimization. Structure guided drug design led to the identification of (R)-2-phenylpyrrolidine substituted imidazopyridazines as a series of potent, selective, orally bioavailable pan-TRK inhibitors achieving tumor regression in rats bearing KM12 xenografts. From this work the (R)-2-phenylpyrrolidine has emerged as an ideal moiety to incorporate in bicyclic TRK inhibitors by virtue of its shape complementarity to the hydrophobic pocket of TRKs.


Tetrahedron Letters | 1995

Diastereoselective synthesis of highly functionalized tetrahydropyrans from the cyclic vinyl acetal with aldehydes mediated by lewis acid catalyst

Chan-Mo Yu; Won-Hyuk Jung; Ha-Soon Choi; Jongho Lee; Jeon-Koo Lee

Abstract A new method for constructing substituted tetrahydropyrans from the conjunction of 6-ethylthio-3,4-dihydro-2-methoxy-2 H -pyran with aldehydes in the presence of 10 mol % SnCl 4 is described. This reaction is highly stereocontrolled and allows various functionalities to be incorporated at tetrahydropyran ring.


Chemical Communications | 1997

CATALYTIC ASYMMETRIC PROP-2-YNYLATION INVOLVING THE USE OF THE BIFUNCTIONAL SYNERGETIC REAGENT ET2BSPRI

Chan-Mo Yu; Sook-Kyung Yoon; Ha-Soon Choi; Kwangwoo Baek

Efficient catalytic asymmetric prop-2-ynylation of achiral aldehydes with allenyltributylstannane promoted by a BINOL–Ti IV complex (10 mol%) is achieved with high enantioselectivity by the use of Et 2 BSPr i .


Chemical Communications | 1997

Bifunctional molecular accelerator for catalytic asymmetricallylation: R2MSR′ (M = B, Al) as a useful synergeticreagent

Chan-Mo Yu; Ha-Soon Choi; Won-Hyuk Jung; Hyuk-Jun Kim; Jaewook Shin

Dramatic acceleration of the catalytic process of asymmetric allylation of achiral aldehydes is observed by the utilization of the bifunctional synergetic reagents R 2 MSR′ (M = B, Al).


Journal of The Chemical Society-perkin Transactions 1 | 1996

Self-regulated molecular rearrangement: diastereoselective zwitterionic aza-Claisen protocol

Chan-Mo Yu; Ha-Soon Choi; Jongho Lee; Won-Hyuk Jung; Hyuk-Jun Kim

Treatment of N-but-2-enylpiperidine with acyl halides in the presence of K2CO3 afforded the corresponding Claisen products with high diastereoselectivity depending on the E or Z but-2-enyl geometry.


Archive | 2005

Compounds and compositions as inhibitors of cannabinoid receptor 1 activity

Hong Liu; Xiaohui He; Ha-Soon Choi; Kunyong Yang; David H. Woodmansee; Zhicheng Wang; David Archer Ellis; Baogen Wu; Yun He; Truc Ngoc Nguyen

Collaboration


Dive into the Ha-Soon Choi's collaboration.

Top Co-Authors

Avatar

Yun He

Chongqing University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Phil S. Baran

Scripps Research Institute

View shared research outputs
Top Co-Authors

Avatar

Yong-Li Zhong

Scripps Research Institute

View shared research outputs
Top Co-Authors

Avatar

Won Hyung Yoon

University of California

View shared research outputs
Top Co-Authors

Avatar

Kin Chiu Fong

Hong Kong University of Science and Technology

View shared research outputs
Top Co-Authors

Avatar

Zhicheng Wang

Genomics Institute of the Novartis Research Foundation

View shared research outputs
Top Co-Authors

Avatar

Baogen Wu

Genomics Institute of the Novartis Research Foundation

View shared research outputs
Top Co-Authors

Avatar

Kunyong Yang

Genomics Institute of the Novartis Research Foundation

View shared research outputs
Top Co-Authors

Avatar

Truc Ngoc Nguyen

Genomics Institute of the Novartis Research Foundation

View shared research outputs
Researchain Logo
Decentralizing Knowledge